OneMedNet regains compliance with Nasdaq listing requirements

OneMedNet (ONMD) announced that the Company regained compliance with Nasdaq Listing Rule 5550(b)(2) after the market value of the Company’s common stock exceeded $35,000,000 for 10 consecutive business days. The Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market confirming compliance with the Rule. As a result, the Company has cleared all listing deficiency notices issued by Nasdaq. Aaron Green, Chief Executive Officer, stated, “We are pleased to have now achieved compliance with the Nasdaq listing rules. This accomplishment will enable us to focus in 2025 on growing our revenue and business operations.”